Close
Show

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

PharmaDiagnostics appoints director of assay development


PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does...

Patent plethora in 2010 breaks record for Biocitech technology park residents


Biocitech SAS, the Paris life science technology park, today announced that its 25 resident companies...

Apricus Biosciences Announced European Patient Coverage For Mycova For Nail Fungus


Apricus Biosciences, Inc. announced that the European Patent Office will grant a patent for the...

Trophos successfully completes phase 1 study for novel cardioprotective compound, TRO40303


Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation...

Novartis gains positive CHMP opinion for Rasilamlo(TM), a single-pill combination of aliskiren and amlodipine...


The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive...

PharmaDiagnostics awarded European patent for label-free SoPRano ADME assays


PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does...

CIT and Stemina Biomarker Discovery announce partnership in Europe for stem cell based toxicology...


CIT – Safety and Health Research Laboratories and Stemina Biomarker Discovery, Inc. announced that CIT...

Personalized medicine: The partnership imperative


Cecilia Schott, business development director for personalized healthcare with AstraZeneca, on why partnerships between pharmaceutical...

Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License...


Eli Lilly and Company announced that the Mirror Portfolio, a concept created by Lilly to...

Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada(R)...


Gilead Sciences, Inc. announced that it has refiled a New Drug Application (NDA) with the...